Clinical Trial

Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This trial is designed to assess the tolerability, safety, pharmacokinetic profile, and preliminary efficacy of the combination of ZGGS18 and ZG005 in patients with advanced solid tumors, including advanced cervical cancer, hepatocellular carcinoma, neuroendocrine cancer, and lung cancer.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-14.
Status change: Not Yet Recruiting → Recruiting 2025-12-30
Trial Details
NCT Number NCT06938880
Lead Sponsor Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Conditions Advanced Solid Tumor
Enrollment 60 participants
Start Date 2025-05-20
Primary Completion 2027-05 (estimated)
Study Completion 2028-04 (estimated)
Updated on ClinicalTrials.gov 2026-01-05